article thumbnail

AI-discovered ALS drug trial uses unique remote monitoring

Drug Discovery World

Verge Genomics has initiated a Phase Ib proof-of-concept study for the treatment of sporadic and familial forms of amyotrophic lateral sclerosis (ALS) with VRG50635. ” The post AI-discovered ALS drug trial uses unique remote monitoring appeared first on Drug Discovery World (DDW).

article thumbnail

Patients achieve 19% weight loss in obesity drug trial

Drug Discovery World

New data from Boehringer Ingelheim and Zealand Pharma has demonstrated superior efficacy with survodutide (also known as BI 456906) versus placebo in people with overweight or obesity without type 2 diabetes after 46 weeks of treatment. Current treatments for obesity mainly focus on weight loss by reducing energy intake.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Psychedelic depression drug trial shows rapid and robust response

Drug Discovery World

The efficacy demonstrated at that dosage showed an unprecedented reduction in depressive symptoms compared to currently available treatments,” said Doug Drysdale, Chief Executive Officer of Cybin. The post Psychedelic depression drug trial shows rapid and robust response appeared first on Drug Discovery World (DDW).

article thumbnail

Scleroderma drug trial shows up to 60% improvement

Drug Discovery World

Treatment with FT011 for 12 weeks resulted in a clinically meaningful improvement in 60% of patients treated with FT011 400mg and 20% of patients in the FT011 200mg group compared with 10% in the placebo group. The post Scleroderma drug trial shows up to 60% improvement appeared first on Drug Discovery World (DDW).

article thumbnail

Phase III pulmonary fibrosis drug trial fails

Drug Discovery World

Bellerophon Therapeutics has announced it will close its Phase III study of INOpulse, its treatment for fibrotic Interstitial Lung Disease (fILD), after the trail failed to meet its primary endpoint. The post Phase III pulmonary fibrosis drug trial fails appeared first on Drug Discovery World (DDW). minutes per day.

article thumbnail

First patient dosed in ulcerative colitis drug trial

Drug Discovery World

A Phase I clinical trial has begun evaluating Direct Biologics’ ExoFlo for the treatment of patients with medically refractory ulcerative colitis (UC). These patients will be randomised to treatment with intravenous ExoFlo every month or every other month over the course of one year.

article thumbnail

What are the top disease areas for clinical drug trials?

Drug Discovery World

Capivasertib could offer a completely new treatment option for these patients. This is great news for men, and we hope that this temporary approval leads to the treatment being rolled out permanently across the UK.” 4. The data showed a complete response in all 14 patients who received dostarlimab as a first-line treatment.

Trials 130